bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
GeneTex circadian rhythm antibodies
Circadian rhythms are physical, behavioural and mental changes that respond primarily to the...
Enzo Life Sciences SCREEN-WELL Cardiotoxicity Library
The SCREEN-WELL Cardiotoxicity Library from Enzo Life Sciences is a focused collection of 130...
HUABIO Cytokeratin 4 Recombinant Rabbit Monoclonal Antibody
Cytokeratin 4 is expressed in the suprabasal layer of the stratified epithelium of the...
